Skip to main content
Clinical Trials/NCT03966547
NCT03966547WithdrawnNot Applicable

Changes in Cerebral Blood Flow (CBF) in Prone and Sitting Position Before and After GSP-block and Before and After Epidural Blood-patch: A Substudy of NCT03652714

University Hospital Bispebjerg and Frederiksberg2 sites in 1 countryStarted: May 1, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Sponsor
Locations
2
Primary Endpoint
Comparison of paint rating (0-100 on a visual analogue scale, VAS) and Cerebral Blood Flow velocity (CBF) before and after each intervention.

Study Overview

Brief Summary

The purpose of this optional sub-study to GSPB-2018 (NCT03652714) is to evaluate the changes in cerebral blood flow (CBF) under different conditions to understand if postdural puncture headache is caused by changes in the cerebral blood flow and if treatment normalises that change.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Study Population:
  • •Subjects who have consented to participate in GSPB-2018 will be approached for participation in this sub-study. Subjects who have consented to participate in GSPB-2018 are not required to participate in this sub-study.
  • •Inclusion Criteria:
  • •Age > 18 years
  • •Patients with postdural puncture headache defined as moderate to severe postural headache (VAS >= 30mm) after lumbar puncture or accidental dural puncture during epidural insertion with an onset within 3 days following the puncture.
  • •Lack of headache remission within 1 day after dural puncture and after treatment with fluids, caffeine and paracetamol
  • •Patients who have given their written informed consent for participation in the study and substudy after fully understanding the protocol content and limitations.

Exclusion Criteria

  • •Patients who cannot cooperate to the study
  • •Patients who does not understand or speak Danish
  • •Allergy to the drugs used in the study
  • •Has taken opioids within 12 hours prior to intervention
  • •No possible transcranial window on transcranial doppler. If not possible to find a useable window to get measurement the patient will be excluded and replaced with another patient.

Arms & Interventions

Isotonic NaCl

Placebo Comparator

Intervention: Ganglion sphenopalatine block with placebo administered on study GSPB-2018 (Procedure)

Local anesthetic

Experimental

Intervention: Ganglion sphenopalatine block with local anesthetic administered on study GSPB-2018 (Procedure)

Outcomes

Primary Outcomes

Comparison of paint rating (0-100 on a visual analogue scale, VAS) and Cerebral Blood Flow velocity (CBF) before and after each intervention.

Time Frame: <1h before and 1 hour after each intervention

Pain intensity measured with a pain rating (0-100mm on a visual analogue scale, VAS) in supine position and as worst experienced pain after the patient has been upright for 30 seconds or the worst experienced pain while attempting to stand if the rating has to be interrupted. Cerebral Blood Flow velocity (CBF) measured as mean blood flow in cm/sec.

Change in Cerebral Blood Flow velcity (CBF) in supine versus upright position compared to effect of treatment.

Time Frame: <1h before and 1 hour after each intervention

Change in mean, minimum and maximum Cerebral Blood Flow velcity in cm/sec (CBF) in supine versus upright position compared to effect of treatment.

Secondary Outcomes

  • Change in Cerebral Blood Flow velocity (CBF) in supine position before and after interventions.(<1h before and 1 hour after each intervention)

Investigators

Sponsor
University Hospital Bispebjerg and Frederiksberg
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mads Seit Jespersen

Medical Doctor, Primary Investigator

University Hospital Bispebjerg and Frederiksberg

Study Sites (2)

Loading locations...

Similar Trials